Meningococcal vax market to reach $3.8B by 2019; Gates funds $1.4B vaccine cooler grant;

> The market for meningococcal vaccines should reach $3.76 billion globally in 2019, a new report says. Release

> The Bill & Melinda Gates Foundation has granted $1.4 billion to The Sure Chill Company, which is developing a vaccine cooler that can go without power for more than 35 days. More

> Vaxart has appointed John Harland as its CFO. Release

> New follow-up data from Novavax ($NVAX) suggest its RSV vaccine may warrant annual boosts. More

> African governments have pledged $700 million to fund vaccine purchase between 2016 and 2020. Report

And Finally... The Federal Circuit last week refused to take up a woman's case against the U.S. Department of Health and Human Services claiming her son's autism was caused by vaccines. More (sub. req.)

Suggested Articles

CEPI, which started to help prepare the world for new outbreaks, has awarded Inovio and Moderna money for vaccine work against the new coronavirus.

As a new coronavirus spreads, vaccine researchers have started work on candidates against the virus—and one could enter the clinic in a few months.

Merck's HPV vaccine Gardasil is delivering blockbuster sales as demand surges. But high demand has caused somewhat of a supply constraint.